Pharma-Bio Serv (PBSV) Current Assets (2010 - 2026)

Pharma-Bio Serv (PBSV) has reported Current Assets for 16 consecutive years, with $11.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Assets fell 15.88% year-over-year to $11.3 million; the trailing twelve-month figure through Apr 2026 stood at $11.3 million (down 15.88% YoY), and the FY2025 full-year result was $13.4 million, down 14.73% from the prior year.
• Current Assets retreated to $11.3 million in Q2 2026 per PBSV's latest filing, from $13.3 million in the prior quarter.
• Across five years, Current Assets topped out at $21.0 million in Q1 2022 and bottomed at $11.3 million in Q2 2026.
• Historically, Current Assets has averaged $16.9 million across 5 years, with a median of $17.6 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Current Assets retreated 28.52% in 2022, then advanced 0.75% in 2023.
• Over 5 years, Current Assets stood at $19.9 million in 2022, then decreased by 2.72% to $19.4 million in 2023, then decreased by 19.08% to $15.7 million in 2024, then retreated by 14.73% to $13.4 million in 2025, then declined by 15.69% to $11.3 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $11.3 million, $13.3 million, and $13.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.